“一带一路”背景下我国与欧盟的中药贸易现状分析及发展策略思考  

Analysis and Development Strategies of Chinese Medicine Trade in the EU Under the“Belt and Road Initiative”

作　　者：张囡 李丝雨 刘国秀 史楠楠[2] 王燕平[2] 翟华强[1] ZHANG Nan;LI Si-yu;LIU Guo-xiu;SHI Nan-nan;WANG Yan-ping;ZHAI Hua-qiang(Standardization Research Center of Traditional Chinese Medicine Dispensing,Beijing University of Chinese Medicine,Beijing 102488,China;Institute of Basic Research in Clinical Medicine,China Academy of Chinese Medical Sciences,Beijing 100700,China)

机构地区：[1]北京中医药大学中药调剂标准化研究中心,北京102488 [2]中国中医科学院中医临床基础医学研究所,北京100700

出　　处：《中国现代中药》2022年第11期2222-2227,共6页Modern Chinese Medicine

基　　金：国家重点研发计划项目(2019YFC1712000);中医临床药学服务与调剂教育国际标准研制项目(2019YFC1712002)。

摘　　要：随着“一带一路”倡议的实施,中国与欧洲、亚洲和非洲地区国家的中医药合作日益密切,中医药在欧洲联盟(以下简称欧盟)市场的发展潜力巨大。以“欧盟”“中医药”“中药贸易”等为关键词,检索中国知网、万方等数据库和相关研究报告,分析“一带一路”倡议提出后我国与欧盟国家的中医药贸易现状与市场需求,并以“一带一路”等系列政策为背景,梳理并分析欧盟现行的中医药相关政策,提出推动与欧盟中医药贸易发展的策略。With the implementation of the"Belt and Road Initiative",the cooperation of traditional Chinese medicine(TCM)between China and countries in Europe,Asia,and Africa is increasingly vigorous,and TCM has huge market potential in the European Union(EU).The research articles were retrieved from databases,such as CNKI and Wanfang Data,and related reports with keywords"EU","TCM","TCM Trade",etc.,and analyzed for the current situation and market demand of TCM trade between China and countries in EU since the implementation of the"Belt and Road Initiative".Furthermore,the present study summarized and analyzed the current TCM policies in EU countries to propose strategies to promote the TCM trade with the EU under the"Belt and Road Initiative".

关 键 词：“一带一路” 欧盟 中医药 贸易 现状分析 发展策略 

分 类 号：R284[医药卫生—中药学]